BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 15489350)

  • 1. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
    Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
    Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
    Awasthi S; Vilekar P; Conkleton A; Rahman N
    Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
    Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
    J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
    Silva AJ; Mohan A; Benitez JA
    Vaccine; 2003 Dec; 21(32):4715-21. PubMed ID: 14585681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
    Kirkland TN; Raz E; Datta SK
    Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
    Jiang C; Magee DM; Cox RA
    Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.